Company Lg Pharm Srl with Fiscal Code 22972425
recorded a turnover of 2024 of
2.228.000,
with a net profit of
360.896
and having an average number of employees of
12.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Lg Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
909.106
767.872
1.133.374
983.266
1.073.312
998.846
1.475.871
1.653.449
2.019.291
2.228.000
Total Income - EUR
914.748
774.851
1.139.448
983.662
1.101.944
999.254
1.480.235
1.654.814
2.024.924
2.241.394
Total Expenses - EUR
561.979
513.513
754.867
673.735
811.929
724.210
1.178.858
1.313.107
1.684.094
1.818.380
Gross Profit/Loss - EUR
352.769
261.339
384.580
309.926
290.015
275.044
301.377
341.707
340.830
423.014
Net Profit/Loss - EUR
295.843
220.243
324.380
261.178
269.751
238.169
275.787
294.400
293.561
360.896
Employees
7
7
7
9
9
9
9
9
10
12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 11.0%, from 2.019.291 euro in the year 2023, to 2.228.000 euro in 2024.
The Net Profit increased by 68.976 euro, from 293.561 euro in 2023, to 360.896 in the last year.
Check the financial reports for the company - Lg Pharm Srl
Financial Rating - LG PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Lg Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Lg Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Lg Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Lg Pharm Srl - CUI 22972425
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
37.787
26.178
14.713
31.547
52.175
75.386
84.786
162.920
161.018
154.239
Current Assets
501.913
407.156
527.942
518.414
549.338
603.680
1.002.610
884.979
910.947
897.996
Inventories
74.908
101.726
117.597
136.162
173.958
269.754
211.457
230.502
298.917
331.015
Receivables
228.371
214.126
336.181
328.605
351.575
302.471
519.784
483.490
679.838
609.660
Cash
198.634
91.303
74.164
53.647
23.805
31.456
271.368
170.988
-67.808
-42.679
Shareholders Funds
345.360
220.296
324.432
261.230
419.004
482.628
524.590
294.448
587.117
485.086
Social Capital
0
45
44
43
42
41
40
41
40
40
Debts
195.794
214.436
219.573
290.399
183.877
198.201
564.977
755.689
487.485
570.243
Income in Advance
0
0
0
0
0
0
0
834
1.513
414
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
897.996 euro in 2024 which includes Inventories of
331.015 euro, Receivables of
609.660 euro and cash availability of
-42.679 euro.
The company's Equity was valued at
485.086 euro, while total Liabilities amounted to
570.243 euro.
Equity decreased by -98.750 euro, from 587.117 euro in 2023, to 485.086 in 2024.
The Debt Ratio was 54.0% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Lg Pharm Srl